Renal Arterial Resistive Index for Differential Diagnosis of Acute Kidney Injury
NCT ID: NCT05409690
Last Updated: 2022-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2022-05-10
2022-11-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Renal Resistive Index (RI) in Predicting Acute Kidney Injury Progression in Intensive Care Clinic
NCT06995222
RDRI and NGAL in Acute Kidney Injury in Abdominal Surgery
NCT05929573
Emergency Department Management of Patients With Renal Infarction
NCT06515379
Renal Resistive Index in Early Detection of Postoperative Acute Kidney Injury
NCT06791304
Sonographic Venous Doppler Imaging in Acute Kidney Injury
NCT04948710
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. patient with acute kidney injury diagnosed according to KDIGO, AKIN or RIFLE criteria
Exclusion Criteria
2. patients receiving renal replacement treatment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara Diskapi Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bedriye Muge Sonmez
asossicated professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Diskapi Research and Training Hospital
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AnkaraDiskapiTRHAKI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.